Heart failure (HF) after myocardial infarction (MI) is a global health issue with a high mortality rate. Multiple molecular mechanisms are involved in the development of HF after MI. However, interventions targeting these pathological processes alone remain clinically ineffective.
This article was originally published on MedicalXpress.com